Relapse to alcohol abuse is an important clinical issue that is frequently caused by cue-induced drug craving. Therefore, disruption of the memory for the cue-alcohol association is expected to prevent relapse. It is increasingly accepted that memories become labile and erasable soon after their reactivation through retrieval during a memory reconsolidation process that depends on protein synthesis. Here we show that reconsolidation of alcohol-related memories triggered by the sensory properties of alcohol itself (odor and taste) activates mammalian target of rapamycin complex 1 (mTORC1) in select amygdalar and cortical regions in rats, resulting in increased levels of several synaptic proteins. Furthermore, systemic or central amygdalar inhibition of mTORC1 during reconsolidation disrupts alcohol-associated memories, leading to a long-lasting suppression of relapse. Our findings provide evidence that the mTORC1 pathway and its downstream substrates are crucial in alcohol-related memory reconsolidation and highlight this pathway as a therapeutic target to prevent relapse.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
World Health Organization. WHO Global Status Report on Alcohol 2004 (Geneva, World Health Organization, 2004).
Johnson, B.A. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem. Pharmacol. 75, 34–56 (2008).
Sinha, R. New findings on biological factors predicting addiction relapse vulnerability. Curr. Psychiatry Rep. 13, 398–405 (2011).
Milton, A. Drink, drugs and disruption: memory manipulation for the treatment of addiction. Curr. Opin. Neurobiol. published online, http://dx.doi.org/10.1016/j.conb.2012.11.008 (21 December 2012).
Nader, K. & Hardt, O. A single standard for memory: the case for reconsolidation. Nat. Rev. Neurosci. 10, 224–234 (2009).
Dudai, Y. Reconsolidation: the advantage of being refocused. Curr. Opin. Neurobiol. 16, 174–178 (2006).
Lee, J.L., Milton, A.L. & Everitt, B.J. Reconsolidation and extinction of conditioned fear: inhibition and potentiation. J. Neurosci. 26, 10051–10056 (2006).
Xue, Y.X. et al. A memory retrieval-extinction procedure to prevent drug craving and relapse. Science 336, 241–245 (2012).
Milton, A.L. et al. Antagonism at NMDA receptors, but not β-adrenergic receptors, disrupts the reconsolidation of pavlovian conditioned approach and instrumental transfer for ethanol-associated conditioned stimuli. Psychopharmacology (Berl.) 219, 751–761 (2012).
Miller, C.A. & Sweatt, J.D. Amnesia or retrieval deficit? Implications of a molecular approach to the question of reconsolidation. Learn. Mem. 13, 498–505 (2006).
Nader, K., Schafe, G.E. & Le Doux, J.E. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 406, 722–726 (2000).
Hoeffer, C.A. & Klann, E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67–75 (2010).
Stoica, L. et al. Selective pharmacogenetic inhibition of mammalian target of rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc. Natl. Acad. Sci. USA 108, 3791–3796 (2011).
Wang, X. et al. Nucleus accumbens core mammalian target of rapamycin signaling pathway is critical for cue-induced reinstatement of cocaine seeking in rats. J. Neurosci. 30, 12632–12641 (2010).
Bailey, J., Ma, D. & Szumlinski, K.K. Rapamycin attenuates the expression of cocaine-induced place preference and behavioral sensitization. Addict. Biol. 17, 248–258 (2012).
Jobim, P.F. et al. Inhibition of mTOR by rapamycin in the amygdala or hippocampus impairs formation and reconsolidation of inhibitory avoidance memory. Neurobiol. Learn. Mem. 97, 105–112 (2012).
Jobim, P.F. et al. Impairment of object recognition memory by rapamycin inhibition of mTOR in the amygdala or hippocampus around the time of learning or reactivation. Behav. Brain Res. 228, 151–158 (2012).
Blundell, J., Kouser, M. & Powell, C.M. Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation. Neurobiol. Learn. Mem. 90, 28–35 (2008).
Glover, E.M., Ressler, K.J. & Davis, M. Differing effects of systemically administered rapamycin on consolidation and reconsolidation of context vs. cued fear memories. Learn. Mem. 17, 577–581 (2010).
Gafford, G.M., Parsons, R.G. & Helmstetter, F.J. Consolidation and reconsolidation of contextual fear memory requires mammalian target of rapamycin-dependent translation in the dorsal hippocampus. Neuroscience 182, 98–104 (2011).
Barak, S., Carnicella, S., Yowell, Q.V. & Ron, D. Glial cell line–derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking. J. Neurosci. 31, 9885–9894 (2011).
Barak, S., Ahmadiantehrani, S., Kharazia, V. & Ron, D. Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption. Transl. Psychiatry 1, e60 (2011).
Carnicella, S., Amamoto, R. & Ron, D. Excessive alcohol consumption is blocked by glial cell line–derived neurotrophic factor. Alcohol 43, 35–43 (2009).
Laplante, M. & Sabatini, D.M. mTOR signaling in growth control and disease. Cell 149, 274–293 (2012).
Wang, D.O., Martin, K.C. & Zukin, R.S. Spatially restricting gene expression by local translation at synapses. Trends Neurosci. 33, 173–182 (2010).
Liu-Yesucevitz, L. et al. Local RNA translation at the synapse and in disease. J. Neurosci. 31, 16086–16093 (2011).
Costa-Mattioli, M., Sossin, W.S., Klann, E. & Sonenberg, N. Translational control of long-lasting synaptic plasticity and memory. Neuron 61, 10–26 (2009).
Takei, N. et al. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J. Neurosci. 24, 9760–9769 (2004).
Lee, C.C., Huang, C.C., Wu, M.Y. & Hsu, K.S. Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt–mammalian target of rapamycin signaling pathway. J. Biol. Chem. 280, 18543–18550 (2005).
Li, N. et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959–964 (2010).
Schratt, G.M., Nigh, E.A., Chen, W.G., Hu, L. & Greenberg, M.E. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase–dependent pathway during neuronal development. J. Neurosci. 24, 7366–7377 (2004).
Maren, S. Synaptic mechanisms of associative memory in the amygdala. Neuron 47, 783–786 (2005).
Xu, W. PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity. Curr. Opin. Neurobiol. 21, 306–312 (2011).
Korb, E. & Finkbeiner, S. Arc in synaptic plasticity: from gene to behavior. Trends Neurosci. 34, 591–598 (2011).
Plath, N. et al. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 52, 437–444 (2006).
Wang, J. et al. Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse. J. Neurosci. 30, 10187–10198 (2010).
Carnicella, S., Kharazia, V., Jeanblanc, J., Janak, P.H. & Ron, D. GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc. Natl. Acad. Sci. USA 105, 8114–8119 (2008).
Parsons, R.G., Gafford, G.M. & Helmstetter, F.J. Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons. J. Neurosci. 26, 12977–12983 (2006).
Everitt, B.J., Cardinal, R.N., Hall, J., Parkinson, J. & Robbins, T. Differential involvement of amygdala subsystems in appetitive conditioning and drug addiction. in The Amygdala: a Functional Analysis (ed. Aggleton, J.P.) 353–390 (Oxford University Press, 2000).
Calu, D.J., Roesch, M.R., Haney, R.Z., Holland, P.C. & Schoenbaum, G. Neural correlates of variations in event processing during learning in central nucleus of amygdala. Neuron 68, 991–1001 (2010).
Purgert, R.J., Wheeler, D.S., McDannald, M.A. & Holland, P.C. Role of amygdala central nucleus in aversive learning produced by shock or by unexpected omission of food. J. Neurosci. 32, 2461–2472 (2012).
Mahler, S.V. & Berridge, K.C. Which cue to “want?” Central amygdala opioid activation enhances and focuses incentive salience on a prepotent reward cue. J. Neurosci. 29, 6500–6513 (2009).
Lingawi, N.W. & Balleine, B.W. Amygdala central nucleus interacts with dorsolateral striatum to regulate the acquisition of habits. J. Neurosci. 32, 1073–1081 (2012).
Pickens, C.L. et al. Neurobiology of the incubation of drug craving. Trends Neurosci. 34, 411–420 (2011).
Davis, M., Walker, D.L., Miles, L. & Grillon, C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35, 105–135 (2010).
Koob, G.F. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Curr. Top. Behav. Neurosci. 13, 3–30 (2013).
Hopf, F.W. et al. Reduced nucleus accumbens SK channel activity enhances alcohol seeking during abstinence. Neuron 65, 682–694 (2010).
Besheer, J. et al. Metabotropic glutamate receptor 5 activity in the nucleus accumbens is required for the maintenance of ethanol self-administration in a rat genetic model of high alcohol intake. Biol. Psychiatry 67, 812–822 (2010).
Neasta, J., Ben Hamida, S., Yowell, Q., Carnicella, S. & Ron, D. Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders. Proc. Natl. Acad. Sci. USA 107, 20093–20098 (2010).
Tronson, N.C. & Taylor, J.R. Molecular mechanisms of memory reconsolidation. Nat. Rev. Neurosci. 8, 262–275 (2007).
Banko, J.L. et al. The translation repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the hippocampus. J. Neurosci. 25, 9581–9590 (2005).
Puighermanal, E. et al. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 12, 1152–1158 (2009).
Cunningham, C.L., Gremel, C.M. & Groblewski, P.A. Drug-induced conditioned place preference and aversion in mice. Nat. Protoc. 1, 1662–1670 (2006).
This work was supported by US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism grant P50 AA017072 (D.R. and P.H.J.) and funds from the State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco (D.R. and P.H.J.). We thank S. Carnicella for critical review of the manuscript.
The authors declare no competing financial interests.
About this article
Cite this article
Barak, S., Liu, F., Hamida, S. et al. Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse. Nat Neurosci 16, 1111–1117 (2013). https://doi.org/10.1038/nn.3439
Effects of heroin self-administration and forced withdrawal on the expression of genes related to the mTOR network in the basolateral complex of the amygdala of male Lewis rats
BMC Biology (2021)
Molecular Psychiatry (2021)
Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice
Nature Communications (2021)
Biogenesis, physiological functions and potential applications of extracellular vesicles in substance use disorders
Cellular and Molecular Life Sciences (2021)